Main Office
Irvine, CA
Other locations
San Francisco, CA
Stuttgart, Germany
Contact Us
  1. Xu S, Liao S, et al. Population pharmacokinetic and exposure-response analyses for daratumumab in combination therapies for patients with multiple myeloma who have received 1 or more prior lines of therapy, ASH Annual Meeting and Exposition, 2016.
  2. Tippin T, Liao S, et al. Determination of the effect of cyclosporine on brincidofovir (CMX001, BCV) using a population pharmacokinetic model, ACCP 2015.
  3. Nichols AI, Liao S, Population pharmacokinetics of desvenlafaxine: pharmacokinetics in Korean vs. US populations. ASCPT abstract, 2013
  4. Leu JH, Beutler A, Mendelsohn A, Davis HM, Zhou H, Xu Z and Liao S, Lack of correlation between golimumab exposure and selected safety events following intravenous or subcutaneous administration in an integrated analysis of phase 3 data of patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis. ACCP abstract, 2013.
  5. Boni J, Ruiz-Garcia A, Liao S, Mugundu G, Vandendries E, modeling the pharmacokinetic/pharmacodynamic platelet response of Inotuzumab ozogamicin, a novel antibody drug conjugate, administered alone or in combination with rituximab in patients with non-Hodgkin’s lymphoma. ESMO abstract, 2010.
  6. Boni J, Liao S, Patel H, Sonnichsen D, Population pharmacokinetic/ pharmacodynamic modeling of thrombocytopenia in patients with non-Hodgkin’s lymphoma receiving inotuzumab ozogamicin, an anti-CD22 monoclonal antibody calicheamicin conjugate. ASCO abstract, 2009.
  7. Bright MG, Liao S, Frane J. Method to estimate serum IGF-1 concentration during rhIGF-1 treatment using a single blood sample. Endocrine abstract, 2008.
  8. Liao S, Bright MG, Population pharmacokinetics of insulin-like growth factor-1 (IGF-1) in type I and II diabetic patients and in healthy adults. American Diabetes Association abstract, 2004.
  9. Liao S, Bright G, Population pharmacokinetics of insulin-like growth factor-1 (IGF-1) in healthy adults. Endocrine Society abstract, 2003.
  10. Liao S, Liu M, Shaw A, Huang MY, Population pharmacokinetic/pharmacodynamic models for motor response of apomorphine in patients with idiopathic parkinson’s disease. AAPS abstract, 2002.
  11. Liao S, Liu M, Shaw A, Huang MY, Population pharmacokinetic/pharmacodynamic models for motor response of apomorphine in patients with idiopathic parkinson’s disease. AAPS abstract, 2002.
  12. Liao S, Li X, Simulation of clinical trials based on the pk/pd pain relief model of tramadol and acetaminophen combination. PRI Science Day 1998.
  13. Liao S, Palmer M, Fowler C, Nayak RK. Absence of the effect of Levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers. ICAAC abstract, 1995.
  14. Liao S, Palmer M. Comparative bioavailability of Levofloxacin from a 125 mg clinical tablet and a 250 mg market-image tablet administered as a 250 mg single dose in the fasted state to healthy male subjects. AAPS abstract, 1995.
  15. Liao S, Palmer M, Nayak RK. Effect of food on the bioavailability and pharmacodynamics of perindopril. The 5th Symposium on Frontiers in Pharmacokinetics and Pharmacodynamics abstract, 1994.
  16. Liao S, Palmer M, Nayak RK, Doose D. The steady-state pharmacokinetics of Topamax® (Topiramate) and Valproic acid in patients with epilepsy on monotherapy, and during combination therapy. AAPS and AES abstracts, 1994.
  17. Liao S, Palmer M, Nayak RK. Bioavailability of two prototype sustained release formulations of tramadol hydrochloride. AAPS abstract, 1993.
  18. Liao S, Palmer M. Digoxin and Topamax® (Topiramate) drug interaction study in male volunteers. AAPS abstract, 1993.
  19. Liao S. PCSIM, a pharmacokinetic simulation program by the convolution method for PC. AAPS abstract, 1992.
  20. Liao S, Hills, J, Stubbs RJ, Nayak RK. The effect of food on the bioavailability of tramadol. AAPS abstract, 1992.
  21. Liao S, Hills JF, Nayak RK. Pharmacokinetics of tramadol following single and multiple oral doses in man. AAPS abstract, 1992.
  22. Liao SHT, Chao J, Hsieh AL. HPLC assay for navelbine and its metabolites in plasma and urine, AAPS abstract, 1990.
  23. Liao SHT. IPAS (Integrated Pharmacokinetic Analysis System). A Microsoft Windows application program for pharmacokinetic analysis, AAPS abstract, 1990.
  24. Liao SHT, Fleck RJ, Blum MR, Frosolono MF, Findlay JWA. Clinical pharmacokinetics and safety of acrivastine with pseudoephedrine in geriatric volunteers. JUC Pharm SCI abstract, 1987.
  1. SR, Liao S, Payne-Johnson M, Zielinski RJ, Stegemann MR. Population pharmacokinetics of mavacoxib in osteoarthritic dogs. J Vet Pharmacol Ther. 2011 Feb;34(1):1-11.
  2. Zhou H, Hu C, Zhu Y, Lu M, Liao S, Yeilding N, Davis HM. Population-based exposure-efficacy modeling of ustekinumab in patients with moderate to severe plaque psoriasis. J Clin Pharmacol. 2010 Mar;50(3):257-67.
  3. Zhu Y, Hu C, Lu M, Liao S, Marini JC, Yohrling J, Yeilding N, Davis HM, Zhou H. Population pharmacokinetic modeling of ustekinumab, a human monoclonal antibody targeting IL-12/23p40, in patients with moderate to severe plaque psoriasis. J Clin Pharmacol. 2009 Feb;49(2):162-75.
  4. Iyer GR, Liao S and Massarella J, Population analysis of the pharmacokinetics and pharmacodynamics of RWJ-270201 (BCX-1812) in treating experimental influenza A and B virus in healthy volunteers. AAPS PharmSci 2002; 4 (4)
  5. Tao Q, Stone DJ, Borenstein MR, Codd EE, Coogan TP, Desai-Krieger D, Liao S, Raffa RB. Differential tramadol and O-desmethyl metabolite levels in brain vs. plasma of mice and rats administered tramadol hydrochloride orally. J Clin Pharm Ther. 2002 Apr;27(2):99-106
  6. Tao Q, Stone DJ Jr, Borenstein MR, Jean-Bart V, Codd EE, Coogan TP, Desai-Krieger D, Liao S, Raffa RB. Gas chromatographic method using nitrogen-phosphorus detection for the measurement of tramadol and its O-desmethyl metabolite in plasma and brain tissue of mice and rats. J Chromatogr B Biomed Sci Appl. 2001 Nov 5;763(1-2):165-71.
  7. Abdel-Rahman SM, Leeder JS, Wilson JT, Gaedigk A, Gotschall RR, Medve R, Liao S, Spielberg SP, Kearns GL. Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and nonCYP2D6 pathways on biotransformation. J Clin Pharmacol. 2002 Jan;42(1):249.
  8. Rosenfeld WE, Liao S, Kramer LD, Anderson G, Palmer M, Levey RH, Nayak NK. Comparison of the steady-state pharmacokinetics of topiramate and valproic acid in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia 1997;38(3):323-332.
  9. Liao S, Palmer M, Fowler C, Nayak RK. Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers. J Clin Pharmaco 1996; 36(11):1072-1077.
  10. Raffa RB, Nayak RK, Liao S. The mechanism(s) of action and pharmacokinetics of tramadol hydrochloride. Reviews in Contemporary Pharmacotherapy 6/10: 485497, (1995).
  11. Woolley JL, Deangelis DV, Grace ME, Liao SHT, Crouch RC, and Sigel C. The disposition and metabolism of [14C]piritrexim in dogs after intravenous and oral administration Drug Metabolism and Disposition 19/6: 1139-1146, (1991).
  12. Balasubramanian R, Klein KB, Pittman W, Liao SHT, Findlay J, Frosolon MF. Pharmacokinetics of acrivastine after oral and colonic administration. J. Clinical Pharmacology 29: 444-447 (1989).
  13. Weiss GR, Sarosy GA, Shenkkenberf TD, Williams T, Clendenninn NJ, Von Hoff DD, Wooley JL, Liao SHT, Blum MR. A phase I clinical and pharmacological study of weekly intravenous infusion of piritrexim. Eur J Cancer Clin Oncol, 25/12: 1867-1873 (1989).
  14. Blum MR, Liao SHT, de Miranda P. Pharmacokinetics and bioavailability of zidovudine in humans. The American Journal of Medicine 85 (suppl. 2A), 189-194 (1988).
  15. Petty BG, Whitley RJ, Liao SHT, Krasny HC, Rocco LE, Davis G, Lietman PS. Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteers. Anti Agents and Chemother 31: 1317-1322 (1987).
  16. Cohen AF, Hamilton MJ, Liao SHT, Findlay JWA, Peck AW. Pharmacodynamic and pharmacokinetics of BW 825C: A new antihistamine. Eur J Clin pharmacol. 28: 197204 (1985)
  17. Williams BO, Liao SHT, Lai AA, Arnold JD, Perkins JG, Blum MR, Findlay JWA. Bioavailability of pseudoephedrine and triprolidine from combination and single-ingredient products. Clin. Pharm. 3: 636-643 (1984).
  18. Blum MR, Liao SHT, Hajian G. Considerations of linear regression with errors in both variables as applied to clinical pharmacokinetics. Pharmacokinetics: A Modern View, 420¬425 (1984).
  19. Reuning RH, Liao SHT, Staubus AE, Ashcraft SB, Downs DA, Harrigan SE, Wiley JN, Wise DL. Pharmacokinetic quantitation of naltrexone controlled release from a copolymer delivery system. J. Pharmacokinetic Biopharm. 11: 369-387 (1983).
  20. Blum MR, Liao SHT, de Miranda P. Overview of acyclovir pharmacokinetic disposition in adults and children. American Journal of Medicine, Proceedings of a Symposium on Acyclovir, July 20, pp 186-192 (1982).
  21. Krasny HC, Liao SHT, Laskin OL, de Miranda P. Influence of hemodialysis on Acyclovir pharmacokinetics in patients with chronic renal failure. American Journal of Medicine, Proceedings of a Symposium on Acyclovir, July 20, pp 202-204 (1982)
  22. Wilson RC, Cocchetto DM, Blum MR, Liao SHT, Hersh M, Bull JH. KINPLOT: An interactive pharmacokinetic graphic program for digital computers. Am. J. Pharma. Edu. 46: 146-150 (1982).
  23. Reuning RH, Liao SHT, Staubus AE. Pharmacokinetic quantitation of naltrexone release from several sustained release delivery systems. NIDA Research Monograph 28; Narcotic antagonist, naltrexone pharmacochemistry and sustained-release preparations (1981).
  24. Liao SHT. Ph.D. dissertation: Pharmacokinetics of naltrexone and its conjugated metabolites in dogs and rabbits: A study of biliary excretion and enterohepatic recycling. Department of Pharmaceutic Chemistry, School of Pharmacy, the Ohio State University (1979).
  25. Rieske JK, Alben JO, Liao SHT. Sulfhydryl-group perturbations: a) possible probe of confirmational changes in complex II together with observations on the antimycin/oxidant-enhanced reduction of cyctochromes b) Proceedings of the International Symposium on Electron Transfer Chains and Oxidative Phosphorylation, Selva di Frasno, Italy (1975).
  26. Castellino FJ, Thomas TK, Liao SHT, Rawitch AB. Rotational diffusion analysis of confirmational alterations produced in plasminogen by certain antifibrinolytic amino acids. Biochemistry 12: 2787 (1973).